S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Laser breakthrough could send stock soaring 2,467% (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Having Trouble in Your Trading? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Having Trouble in Your Trading? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Laser breakthrough could send stock soaring 2,467% (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Having Trouble in Your Trading? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Having Trouble in Your Trading? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Laser breakthrough could send stock soaring 2,467% (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Having Trouble in Your Trading? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Having Trouble in Your Trading? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
Laser breakthrough could send stock soaring 2,467% (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
Having Trouble in Your Trading? (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Having Trouble in Your Trading? (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NASDAQ:ZYXI

Zynex (ZYXI) Stock Forecast, Price & News

$9.18
-0.13 (-1.40%)
(As of 06/6/2023 ET)
Compare
Today's Range
$9.11
$9.42
50-Day Range
$9.18
$14.56
52-Week Range
$6.65
$17.25
Volume
169,300 shs
Average Volume
323,885 shs
Market Capitalization
$336.45 million
P/E Ratio
20.40
Dividend Yield
N/A
Price Target
$19.63

Zynex MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
113.8% Upside
$19.63 Price Target
Short Interest
Bearish
23.63% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
53.33%
From $0.45 to $0.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Medical Sector

346th out of 981 stocks

Electromedical Equipment Industry

7th out of 20 stocks


ZYXI stock logo

About Zynex (NASDAQ:ZYXI) Stock

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

ZYXI Stock News Headlines

[BREAKING] New "Living Software" to Revolutionize Warfare
This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>
Small A.I. Firm Wins $2 Billion in Contracts for Breakthrough "Living Software"
Denver firm proves its possible to use AI to save the lives of soldiers in combat. England, Germany, Japan and Australia have all signed contracts within the past 18 months. Get the name of the stock here >>>
Zynex (NASDAQ:ZYXI) Updates Q1 2023 Earnings Guidance
Zynex (NASDAQ:ZYXI) Updates FY 2023 Earnings Guidance
Zynex Announces 2023 First Quarter Earnings
Zynex (NASDAQ:ZYXI) Stock Rating Reaffirmed by HC Wainwright
Zynex (NASDAQ:ZYXI) Releases Q1 Earnings Guidance
Zynex (NASDAQ:ZYXI) Issues FY23 Earnings Guidance
Zynex Reports Preliminary First Quarter 2023 Results
See More Headlines

ZYXI Price History

ZYXI Company Calendar

Last Earnings
4/27/2023
Today
6/07/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZYXI
Fax
N/A
Employees
774
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$19.63
High Stock Price Forecast
$28.00
Low Stock Price Forecast
$12.50
Forecasted Upside/Downside
+113.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$17.05 million
Pretax Margin
12.89%

Debt

Sales & Book Value

Annual Sales
$158.17 million
Cash Flow
$0.54 per share
Book Value
$1.77 per share

Miscellaneous

Free Float
19,588,000
Market Cap
$336.45 million
Optionable
Optionable
Beta
0.59

Key Executives

  • Thomas SandgaardThomas Sandgaard
    Chairman, President & Chief Executive Officer
  • Anna Lucsok
    Chief Operating Officer
  • Daniel J. MoorheadDaniel J. Moorhead
    Chief Financial & Accounting Officer
  • Steve Fox
    Vice President-Sales
  • Dave Anttila
    Director-Human Resources













ZYXI Stock - Frequently Asked Questions

Should I buy or sell Zynex stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Zynex in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ZYXI shares.
View ZYXI analyst ratings
or view top-rated stocks.

What is Zynex's stock price forecast for 2023?

3 brokerages have issued twelve-month price objectives for Zynex's stock. Their ZYXI share price forecasts range from $12.50 to $28.00. On average, they expect the company's stock price to reach $19.63 in the next year. This suggests a possible upside of 113.8% from the stock's current price.
View analysts price targets for ZYXI
or view top-rated stocks among Wall Street analysts.

How have ZYXI shares performed in 2023?

Zynex's stock was trading at $13.91 at the start of the year. Since then, ZYXI stock has decreased by 34.0% and is now trading at $9.18.
View the best growth stocks for 2023 here
.

When is Zynex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our ZYXI earnings forecast
.

How were Zynex's earnings last quarter?

Zynex, Inc. (NASDAQ:ZYXI) posted its quarterly earnings data on Thursday, April, 27th. The company reported $0.04 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.03. The business had revenue of $42.17 million for the quarter, compared to analyst estimates of $39.67 million. Zynex had a net margin of 10.19% and a trailing twelve-month return on equity of 26.02%.

What guidance has Zynex issued on next quarter's earnings?

Zynex issued an update on its first quarter 2023 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of 0-$0.03 for the period, compared to the consensus earnings per share estimate of $0.01. The company issued revenue guidance of $39.00 million-$41.00 million, compared to the consensus revenue estimate of $39.61 million.

What is Thomas Sandgaard's approval rating as Zynex's CEO?

81 employees have rated Zynex Chief Executive Officer Thomas Sandgaard on Glassdoor.com. Thomas Sandgaard has an approval rating of 87% among the company's employees.

What is Zynex's stock symbol?

Zynex trades on the NASDAQ under the ticker symbol "ZYXI."

Who are Zynex's major shareholders?

Zynex's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.28%), State Street Corp (1.87%), Geode Capital Management LLC (1.19%), Anson Funds Management LP (0.00%), Anson Funds Management LP (0.00%) and Bank of New York Mellon Corp (0.74%). Insiders that own company stock include Anna Lucsok, Daniel J Moorhead and Thomas Sandgaard.
View institutional ownership trends
.

How do I buy shares of Zynex?

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $9.18.

How much money does Zynex make?

Zynex (NASDAQ:ZYXI) has a market capitalization of $336.45 million and generates $158.17 million in revenue each year. The company earns $17.05 million in net income (profit) each year or $0.45 on an earnings per share basis.

How many employees does Zynex have?

The company employs 774 workers across the globe.

How can I contact Zynex?

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The official website for the company is www.zynex.com. The company can be reached via phone at (303) 703-4906 or via email at info@zynex.com.

This page (NASDAQ:ZYXI) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -